Fyteko and Anasac Announce Strategic Distribution Agreement for NURSPRAY®HC in Chile

Strategic Partnership Announcement

Fyteko and Anasac Announce Strategic Distribution Agreement for NURSPRAY®HC in Chile

Advancing Plant Signaling Technology for Specialty Export Crops

What is the core focus of the Fyteko and Anasac Announce Strategic Distribution partnership?
Fyteko, a Belgian biotech leader, has partnered with Anasac, Chile’s agricultural giant with over 78 years of experience, to commercialize NURSPRAY®HC. This strategic agreement focuses on bringing advanced plant signaling molecules to the Chilean market, specifically targeting high-value specialty crops such as cherries, table grapes, and apples to meet the rigorous demands of export-driven fruit production.

How does NURSPRAY®HC technology benefit Chilean fruit growers?
The technology utilizes a single, well-defined active molecule developed through green chemistry to activate specific plant signaling pathways. Extensive field evaluations conducted in Chile during 2024 and 2025 have validated the product’s ability to consistently improve post-harvest quality and overall crop performance, providing a scientifically robust alternative to traditional complex biological mixtures.

What makes this agreement a long-term strategic move for both companies?
For Fyteko, this represents a major step in international expansion by leveraging Anasac’s deep market knowledge and vast grower network. For Anasac, the partnership reinforces their Biorrational® line and commitment to sustainable innovation, adding a “new class” of signaling solutions to their portfolio that aligns with global food security challenges and precision agriculture trends.

Read Whole News Here

Fyteko, a Belgian biotech company pioneering a new generation of plant signaling solutions, announces a new partnership with Anasac, one of Chile’s leading agricultural input companies with more than 78 years of market presence. The agreement covers the commercialization of NURSPRAY®HC in Chile, initially targeting cherries, table grapes, and apples, with plans to expand into additional specialty crops.

Signal Molecule Technology

Unlike complex mixtures, NURSPRAY®HC is based on a single, well-defined active molecule with a clear mode of action—delivering consistency and reproducibility. Developed using enzymatic synthesis and green chemistry principles, this precision molecule activates key plant signaling pathways involved in crop physiology.

Strong validation in Chilean production systems

Extensive field evaluations conducted across multiple locations in Chile in 2024 and 2025 confirmed the consistent performance of NURSPRAY®HC in specialty crops, particularly in cherry, table grape, and apple production systems. These trials showed promising results, demonstrating strong improvements in post-harvest quality and overall crop performance, aligning with the demands of export-driven fruit markets.

Legend: Field trials testing NURSPRAY®HC in table grapes improved post-harvest fruit quality, supporting export-driven market requirements.

A strategic long-term partnership

For Fyteko, the agreement marks a major step in its international expansion, leveraging Anasac’s deep market knowledge, technical expertise, and strong grower network in Chile. For Anasac, the partnership reinforces its commitment to biologicals and next-generation agronomic solutions, expanding its portfolio with a scientifically differentiated technology.

″Anasac shares our vision of bringing scientifically robust and clearly differentiated biological solutions to growers,″ said Guillaume WEGRIA, CEO and co-founder of Fyteko. ″This long-term agreement reflects both the strength of the field data generated in Chile and Anasac’s strong strategic commitment to innovation in specialty crops.″

″NURSPRAY®HC represents a new class of plant solutions based on defined signaling molecules,″ added Gabriel Ormeño, Anasac CEO. ″Its consistent performance and clear mode of action make it a strong fit for our specialty crop portfolio and our long-term strategy in biological inputs.″

About Fyteko

Fyteko is a Belgian agrobiotechnology company dedicated to the development of biosolutions that enhance crop physiological performance and support yield expression, including under abiotic stress conditions. Fyteko’s products—designed for seed and foliar applications—are based on a single active ingredient with a clearly defined mode of action, supported by robust scientific data. Backed by extensive laboratory research and more than 1,000 field trials, Fyteko’s solutions have demonstrated proven and consistent performance.

About Anasac

ANASAC is a Chilean company with over 78 years of experience and a recognized leadership in agriculture. ANASAC offers integrated crop protection solutions, with traditional products and its Biorrational® line, as well as plant welfare, seeds, and veterinary products. Through a strong regional presence, it stands out for its high standards of quality, innovation, and close customer relationships.

Global Context & Discovery

This expansion into South America mirrors global trends where biotech firms are securing strategic regulatory wins. For example, Biotalys’ recent financial report highlights similar momentum in the biocontrol space.

“Fyteko – The science of biopossible.”

Fyteko (Belgium) & ANASAC (Chile) Partnership

May 8, 2026 | visit fyteko.com or anasac.cl

Leave a Reply

Your email address will not be published. Required fields are marked *


View More →